Filing Details
- Accession Number:
- 0000310764-23-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-06 18:17:39
- Reporting Period:
- 2023-02-02
- Accepted Time:
- 2023-02-06 18:17:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310764 | Stryker Corp | SYK | Surgical & Medical Instruments & Apparatus (3841) | 381239739 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1670936 | S Glenn Boehnlein | 2825 Airview Blvd Kalamazoo MI 49002 | Vp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-02 | 7,709 | $277.55 | 19,144 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-02 | 7,708 | $278.38 | 11,436 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-02 | 8,883 | $279.52 | 2,553 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-02 | 125 | $279.96 | 2,428 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,476 | Indirect | By 401K |
Footnotes
- The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $276.92 to $277.82, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $277.94 to $278.935, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $278.94 to $279.92, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $279.96 to $279.97, inclusive. The reporting person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
Billionaire Hedge Funds
